Quick Answer
Medinotec Inc. reported R&D Expense of -$91.1 thousand for fiscal year 2025.
Medinotec Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | -$91.1K | -307.7% |
| 2024 | -$22.4K | +65.5% |
| 2023 | -$64.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $8.3K | -88.0% | -87.4% |
| August 31, 2025 | $66.2K | +3400.8% | +235.1% |
| May 31, 2025 | -$49.0K | -227.2% | -170.8% |
| November 30, 2024 | $69.3K | +2439.2% | +3561.2% |
| August 31, 2024 | $1.9K | -84.0% | +112.6% |
| May 31, 2024 | -$15.0K | -562.3% | -649.2% |
| November 30, 2023 | $2.7K | -57.4% | -77.0% |
| August 31, 2023 | $11.9K | -45.8% | +624.2% |
- Medinotec Inc. showed a decrease of -307.7% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2025 period, Medinotec Inc.’s r&d expense has declined by 40.5% (from -$64.9 thousand to -$91.1 thousand).
- The most recent figure is from Medinotec Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: